ARCHIVES

Bevacizumab And Irinotecan May Increase Survival Of GBM

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Rhoads Renamed Cancer Advisory Board Chairman; L-B’s Frederick Contract Renewed For $12 Million

June 28, 1974

Virus Program Report On Scientific Activities

August 15, 1975

Seven New Initiatives For NIH Common Fund

February 26, 2010

Provenge Met Criteria For Approval, Sponsor Says

May 1, 2009

NCI Community Cancer Centers RFP Issued; Advisors Criticize Project Structure.

November 10, 2006

In Brief: Univ. of Texas Panel Selects Four finalists for M.D. Anderson Cancer Center Presidency

April 19, 1996